We reported previously that Lixelle, which was used for beta-2 microglobuli
n (BMG) adsorption columns, could adsorb not only BMG but also inflammatory
cytokines. We then were interested in the application of Lixelle to patien
ts with systemic inflammatory response syndrome (SIRS) and tried to find ou
t its ability to adsorb microorganism components in vitro using lipopolysac
charide (LPS) (E. coli: B8), endotoxin (ET) containing water, and peptidogl
ycan (PG: Micrococcus luteus). The initial concentrations of each solution
were LPS (ET: 29,135 EU/L), contaminated water (ET: 3,523 EU/L), and PG (67
.1 ng/ml) and 2.5 ml of each of the stock solutions and adjusted diluted so
lutions contained 0.5 ml of Lixelle beads. After shaking at 37 degrees C fo
r 2 h, ET in the solutions was determined by the ET specific-limulus ameboc
yte lysate (ES-LAL) method and PG by the silkworm larbae plasma (SLP) metho
d. The results revealed that even when ET concentrations in LPS and contami
nated water were high, the samples containing Lixelle beads showed signific
ant decreases. There was some adsorption of PG but no significant differenc
es. Thus, Lixelle beads can adsorb not only BMG but also microorganism comp
onents such as ET and PG. These findings, together with the ability to adso
rb inflammatory cytokines by Lixelle, show the possibility of application f
or the treatment of infectious SIRS.